cetirizine has been researched along with HIV Coinfection in 2 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cetirizine has no preventive effect on nevirapine-associated rash." | 2.71 | Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial. ( Allaert, FA; Boukli, N; Caumes, E; David, F; Devidas, A; Dupont, B; Launay, O; Lortholary, O; Patey, O; Piketty, C; Prévoteau du Clary, F; Rey, E; Roudière, L; Tréluyer, JM; Urbinelli, R, 2004) |
| "Rash is the most frequent adverse event associated with nevirapine." | 2.71 | Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 Study. ( Arranz, A; Arroyo, JA; Blanco, JL; Boix, V; Dalmau, D; De la Torre, J; Domingo, P; Force, L; González, A; Gonzalez, J; Knobel, H; Llibre, JM; Mahillo, B; Miró, JM; Montes, ML; Ribera, E; Rivero, A; Rodriguez, D; Sanz, J; Sarasa, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Launay, O | 1 |
| Roudière, L | 1 |
| Boukli, N | 1 |
| Dupont, B | 1 |
| Prévoteau du Clary, F | 1 |
| Patey, O | 1 |
| David, F | 1 |
| Lortholary, O | 1 |
| Devidas, A | 1 |
| Piketty, C | 1 |
| Rey, E | 1 |
| Urbinelli, R | 1 |
| Allaert, FA | 1 |
| Tréluyer, JM | 1 |
| Caumes, E | 1 |
| Knobel, H | 1 |
| Miró, JM | 1 |
| Mahillo, B | 1 |
| Domingo, P | 1 |
| Rivero, A | 1 |
| Ribera, E | 1 |
| Gonzalez, J | 1 |
| Sanz, J | 1 |
| González, A | 1 |
| Blanco, JL | 1 |
| Boix, V | 1 |
| Force, L | 1 |
| Llibre, JM | 1 |
| Dalmau, D | 1 |
| Arroyo, JA | 1 |
| De la Torre, J | 1 |
| Rodriguez, D | 1 |
| Montes, ML | 1 |
| Arranz, A | 1 |
| Sarasa, M | 1 |
2 trials available for cetirizine and HIV Coinfection
| Article | Year |
|---|---|
Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial.
Topics: Adult; Anti-HIV Agents; Cetirizine; Double-Blind Method; Exanthema; Female; Histamine H1 Antagonists | 2004 |
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 Study.
Topics: Cetirizine; Double-Blind Method; Exanthema; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged | 2004 |